Ravi Ramjeesingh, MD, PhD, FRCPC - Immunotherapy for Biliary Tract Cancers: Changing the Narrative in Rare and Aggressive Tumours

Ravi Ramjeesingh, MD, PhD, FRCPC - Immunotherapy for Biliary Tract Cancers: Changing the Narrative in Rare and Aggressive Tumours

Visit https://www.peervoice.com/JRP860 to view the entire programme with slides. After completing “Ravi Ramjeesingh, MD, PhD, FRCPC - Immunotherapy for Biliary Tract Cancers: Changing the Narrative in Rare and Aggressive Tumours”, participants will be abl
10 Minuten
Podcast
Podcaster
Thought leader perspectives on current clinical advances in medicine.

Kommentare (0)

Lade Inhalte...

Abonnenten

15
15